Cargando…

The Influence of Formulation and Manufacturing Process Parameters on the Characteristics of Lyophilized Orally Disintegrating Tablets

Gelatin is a principal excipient used as a binder in the formulation of lyophilized orally disintegrating tablets. The current study focuses on exploiting the physicochemical properties of gelatin by varying formulation parameters to determine their influence on orally disintegrating tablet (ODT) ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jones, Rhys J., Rajabi-Siahboomi, Ali, Levina, Marina, Perrie, Yvonne, Mohammed, Afzal R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857075/ https://www.ncbi.nlm.nih.gov/pubmed/24310589 http://dx.doi.org/10.3390/pharmaceutics3030440

Ejemplares similares

Conceptualisation, Development, Fabrication and In Vivo Validation of a Novel Disintegration Tester for Orally Disintegrating Tablets
por: Koner, Jasdip S., et al.
Publicado: (2019)

Investigation of Formulation and Process of Lyophilised Orally Disintegrating Tablet (ODT) Using Novel Amino Acid Combination
por: AlHusban, Farhan, et al.
Publicado: (2010)

Ingestibility and Formulation Quality of Lansoprazole Orally Disintegrating Tablets
por: Chono, Sumio, et al.
Publicado: (2016)

Pharmacokinetics and pharmacodynamics of an orally disintegrating tablet formulation of dexlansoprazole
por: Kukulka, Michael, et al.
Publicado: (2016)

Formulation and Taste Masking of Ranitidine Orally Disintegrating Tablet
por: Hesari, Zahra, et al.
Publicado: (2016)

Formulation and development of paediatric orally disintegrating carbamazepine tablets
por: Canadell-Heredia, R, et al.
Publicado: (2022)

Formulation Design of Fast Disintegrating Tablets Using Disintegrant Blends
por: Shirsand, S. B., et al.
Publicado: (2010)

Design, Formulation, and Physicochemical Evaluation of Montelukast Orally Disintegrating Tablet
por: Aslani, Abolfazl, et al.
Publicado: (2016)

Predicting oral disintegrating tablet formulations by neural network techniques
por: Han, Run, et al.
Publicado: (2018)

Design, Formulation and Physicochemical Evaluation of Dimenhydrinate Orally Disintegrating Tablets
por: Aslani, Abolfazl, et al.
Publicado: (2018)

Formulation Development, Evaluation and Comparative Study of Effects of Super Disintegrants in Cefixime Oral Disintegrating Tablets
por: Remya, KS, et al.
Publicado: (2010)

Natural Polymer Chitosan as Super Disintegrant in Fast Orally Disintegrating Meloxicam Tablets: Formulation and Evaluation
por: Draksiene, Gailute, et al.
Publicado: (2021)

Efficacy, Safety, and Palatability of RACTAB® Formulation Amlodipine Orally Disintegrating Tablets
por: Fukui-Soubou, Mari, et al.
Publicado: (2012)

Recent Formulation Advances and Therapeutic Usefulness of Orally Disintegrating Tablets (ODTs)
por: Chinwala, Maimoona
Publicado: (2020)

Formulation and Evaluation of a Novel Matrix-Type Orally Disintegrating Ibuprofen Tablet
por: Tayebi, Hoda, et al.
Publicado: (2011)

Formulation and Quality Control of Orally Disintegrating Tablets (ODTs): Recent Advances and Perspectives
por: Ghourichay, Mohammadali Poursharifi, et al.
Publicado: (2021)

Formulation and Evaluation of Rizatriptan Benzoate Mouth Disintegrating Tablets
por: Keny, R. V., et al.
Publicado: (2010)

Formulation and Evaluation of Mouth Disintegrating Tablets of Atenolol and Atorvastatin
por: Sarfraz, R. M., et al.
Publicado: (2015)

A Holistic Multi Evidence Approach to Study the Fragmentation Behaviour of Crystalline Mannitol
por: Koner, Jasdip S., et al.
Publicado: (2015)

Current opinions and recommendations of paediatric healthcare professionals – The importance of tablets: Emerging orally disintegrating versus traditional tablets
por: Alyami, Hamad, et al.
Publicado: (2018)

Enhancing the Low Oral Bioavailability of Sulpiride via Fast Orally Disintegrating Tablets: Formulation, Optimization and In Vivo Characterization
por: M. Tawfeek, Hesham, et al.
Publicado: (2020)

Formulation Optimization and Assessment of Dexamethasone Orally Disintegrating Tablets Using Box-Behnken Design
por: Soroush, Hadis, et al.
Publicado: (2018)

A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets
por: Tawfik, Essam A., et al.
Publicado: (2021)

Formulation and evaluation of taste-masked oral disintegrating tablet containing tolterodine-loaded montmorillonite
por: Taymouri, Somayeh, et al.
Publicado: (2023)

Development of an Age-Appropriate Mini Orally Disintegrating Carvedilol Tablet with Paediatric Biopharmaceutical Considerations
por: Khan, Dilawar, et al.
Publicado: (2021)

Evidence-Based Nanoscopic and Molecular Framework for Excipient Functionality in Compressed Orally Disintegrating Tablets
por: Al-khattawi, Ali, et al.
Publicado: (2014)

Fixed-dose combination orally disintegrating tablets to treat cardiovascular disease: formulation, in vitro characterization and physiologically based pharmacokinetic modeling to assess bioavailability
por: Dennison, Thomas J, et al.
Publicado: (2017)

Formulation of Ebastine Fast-Disintegrating Tablet Using Coprocessed Superdisintegrants and Evaluation of Quality Control Parameters
por: Dhakal, Bhawana, et al.
Publicado: (2022)

Preparation and Evaluation of Directly Compressible Orally Disintegrating Tablets of Cannabidiol Formulated Using Liquisolid Technique
por: Limpongsa, Ekapol, et al.
Publicado: (2022)

Pharmaceutical Evaluation of Levofloxacin Orally Disintegrating Tablet Formulation Using Low Frequency Raman Spectroscopy
por: Yamamoto, Yoshihisa, et al.
Publicado: (2023)

Formulation Design and Optimization of Fast Disintegrating Lorazepam Tablets by Effervescent Method
por: Shirsand, S. B., et al.
Publicado: (2010)

Optimized furosemide taste masked orally disintegrating tablets
por: Ibrahim, Mohamed Abbas, et al.
Publicado: (2017)

Effects of thickened drinks on the disintegration of various oral tablets
por: Matsuo, Taisuke, et al.
Publicado: (2020)

A novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets
por: Li, Feng-Qian, et al.
Publicado: (2011)

Formulation and In-vitro Evaluation of Orally Disintegrating Tablets of Olanzapine-2-Hydroxypropyl-β-Cyclodextrin Inclusion Complex
por: Ajit Shankarrao, Kulkarni, et al.
Publicado: (2010)

Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression
por: Tafere, Chernet, et al.
Publicado: (2021)

The practical approach to the evaluation of methods used to determine the disintegration time of orally disintegrating tablets (ODTs)
por: Brniak, Witold, et al.
Publicado: (2015)

Formulation Development and Evaluation of Fast Disintegrating Tablets of Salbutamol Sulphate for Respiratory Disorders
por: Sharma, Deepak
Publicado: (2013)

Development of the Modified Ocimum gratissimum Seeds for Orally Disintegrating Tablets
por: Dang, Yen N.T., et al.
Publicado: (2020)

Lyophilization of Nanocapsules: Instability Sources, Formulation and Process Parameters
por: Degobert, Ghania, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d6g0u1bb5epu6pbg12tnt8nual